Certolizumab pegol

Red

Brand Name(s):Cimzia

Indication:Rheumatoid arthritis (Moderate to severe)
Axial Spondyloarthritis
Psoriatic arthritis

Rationale:1,2,3

Considered:Mar-10

Review Date:Mar-22

Comments:
NICE NG65
Spondyloarthritis in over 16s: diagnosis and managementSpondyloarthritis in over 16s: diagnosis and management
Feb2017
…………………………
NICE TA 415
Certolizumab pegol for treating rheumatoid arthritis after inadequate response to a TNF-alpha inhibitor
Oct 2016
…………………………
NICE TA 375
Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed.
January 2016

MHRA -Drug Safety Update
Tumour necrosis factor alpha inhibitors: risk of tuberculosis further information at:
http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/CON404195
April 14

NICE TA 186
Certolizumab pegol for the treatment of rheumatoid arthritis February 2010